Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May;39(5):668-76.
doi: 10.2337/dc15-2439. Epub 2016 Mar 29.

Cardiovascular Risk Factor _targets and Cardiovascular Disease Event Risk in Diabetes: A Pooling Project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study

Affiliations

Cardiovascular Risk Factor _targets and Cardiovascular Disease Event Risk in Diabetes: A Pooling Project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study

Nathan D Wong et al. Diabetes Care. 2016 May.

Abstract

Objective: Controlling cardiovascular disease (CVD) risk factors in diabetes mellitus (DM) reduces the number of CVD events, but the effects of multifactorial risk factor control are not well quantified. We examined whether being at _targets for blood pressure (BP), LDL cholesterol (LDL-C), and glycated hemoglobin (HbA1c) together are associated with lower risks for CVD events in U.S. adults with DM.

Research design and methods: We studied 2,018 adults, 28-86 years of age with DM but without known CVD, from the Atherosclerosis Risk in Communities (ARIC) study, Multi-Ethnic Study of Atherosclerosis (MESA), and Jackson Heart Study (JHS). Cox regression examined coronary heart disease (CHD) and CVD events over a mean 11-year follow-up in those individuals at BP, LDL-C, and HbA1c _target levels, and by the number of controlled risk factors.

Results: Of 2,018 DM subjects (43% male, 55% African American), 41.8%, 32.1%, and 41.9% were at _target levels for BP, LDL-C, and HbA1c, respectively; 41.1%, 26.5%, and 7.2% were at _target levels for any one, two, or all three factors, respectively. Being at BP, LDL-C, or HbA1c _target levels related to 17%, 33%, and 37% lower CVD risks and 17%, 41%, and 36% lower CHD risks, respectively (P < 0.05 to P < 0.0001, except for BP in CHD risk); those subjects with one, two, or all three risk factors at _target levels (vs. none) had incrementally lower adjusted risks of CVD events of 36%, 52%, and 62%, respectively, and incrementally lower adjusted risks of CHD events of 41%, 56%, and 60%, respectively (P < 0.001 to P < 0.0001). Propensity score adjustment showed similar findings.

Conclusions: Optimal levels of BP, LDL-C, and HbA1c occurring together in individuals with DM are uncommon, but are associated with substantially lower risk of CHD and CVD.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Unadjusted CVD and CHD event rates per 1,000 person-years for subjects with DM, by status of being at _target level for individual risk factors BP, LDL-C, and HbA1c (A) and by the number of risk factors at _target levels (B). BP _target <130/80 mmHg; LDL-C _target <2.6 mmol/L (100 mg/dL); HbA1c _target <53.0 mmol/mol (7%).

Similar articles

Cited by

References

    1. American Diabetes Association Cardiovascular disease and risk management. Sec. 8. In Standards of Medical Care in Diabetes—2016. Diabetes Care 2016;39(Suppl. 1):S60–S71 - PubMed
    1. Fox CS, Golden SH, Anderson C, et al. .; American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, Council on Quality of Care and Outcomes Research, and the American Diabetes Association . Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2015;132:691–718 - PMC - PubMed
    1. American Diabetes Association Standards of medical care for patients with diabetes mellitus. Diabetes Care 2000;23(Suppl. 1):S32–S42 - PubMed
    1. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–853 - PubMed
    1. Gerstein HC, Miller ME, Byington RP, et al. .; Action to Control Cardiovascular Risk in Diabetes Study Group . Effect of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545–2559 - PMC - PubMed

MeSH terms

Grants and funding

  NODES
Association 8
COMMUNITY 2
Project 3
twitter 2